论文部分内容阅读
目的研究非离子型对比剂碘佛醇在CT静脉增强中的临床应用价值。方法随机选取2014年10月-2015年10月收治的需行CT静脉检查患者120例为研究对象,应用非离子型对比剂碘佛醇进行CT静脉增强检测,观察与评价患者身体耐受性及安全性。结果 120例患者中全身耐受性为佳者112例,大部分患者对该药剂有良好的耐受性;在安全评价上,所有患者均呈轻度反应,持续时间较为短暂,且在后期复查时自行消失。结论在CT静脉增强中应用非离子型对比剂碘佛醇具有良好的安全性与可靠性,能够有效避免患者出现重度不良反应,适用于CT静脉增强检查环节中。
Objective To study the clinical value of non-ionic contrast agent Ivorol in CT vein enhancement. Methods Totally 120 patients undergoing CT venous examination from October 2014 to October 2015 were randomly selected for the study. The non-ionic contrast agent ibuprofen was used to detect CT venous enhancement, and to observe and evaluate the patients’ safety. Results Of the 120 patients, 112 were better tolerated. Most patients were well tolerated with this drug. All patients showed a mild response with a short duration of safety evaluation. In the later review Disappear on its own. Conclusion The application of nonionic contrast agent Ioversol in CT venous enhancement has good safety and reliability, can effectively prevent the occurrence of severe adverse reactions in patients, and is suitable for CT venous enhancement test.